{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:26:51Z","timestamp":1787664411093,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Innovation of Science and Technology of Fujian Province","award":["2023Y9056"],"award-info":[{"award-number":["2023Y9056"]}]},{"name":"the Innovation of Science and Technology of Fujian Province","award":["2021Y9134"],"award-info":[{"award-number":["2021Y9134"]}]},{"name":"Fujian Medical University Undergraduate Innovation and Entrepreneurship Training Program Project","award":["C2025222"],"award-info":[{"award-number":["C2025222"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202200"],"award-info":[{"award-number":["82202200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472012"],"award-info":[{"award-number":["82472012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Provincial Clinical Key Specialty Construction Project","award":["2023SZDZK-HYXK"],"award-info":[{"award-number":["2023SZDZK-HYXK"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00259-025-07625-0","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:49:00Z","timestamp":1761875340000},"page":"2530-2539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["First-in-human study of a novel bifunctional PET tracer [68Ga]Ga-DOTA-NI-FAPI-04 targeting FAP and hypoxia"],"prefix":"10.1007","volume":"53","author":[{"given":"Jie","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hank F.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-4953","authenticated-orcid":false,"given":"Weibing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"7625_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"7625_CR2","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, Jager D, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59:1423\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.210435.","journal-title":"J Nucl Med"},{"key":"7625_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60:801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"key":"7625_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59:1415\u201322. https:\/\/doi.org\/10.2967\/jnumed.118.210443.","journal-title":"J Nucl Med"},{"key":"7625_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/bjr\/tqaf020","author":"M Desaulniers","year":"2025","unstructured":"Desaulniers M, Rousseau E, Pabst KM. Clinical and research applications of FAPI tracers: A review. Br J Radiol. 2025. https:\/\/doi.org\/10.1093\/bjr\/tqaf020.","journal-title":"Br J Radiol"},{"key":"7625_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mvr.2007.05.003","volume":"74","author":"D Fukumura","year":"2007","unstructured":"Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res. 2007;74:72\u201384. https:\/\/doi.org\/10.1016\/j.mvr.2007.05.003.","journal-title":"Microvasc Res"},{"key":"7625_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","volume":"9","author":"MR Horsman","year":"2012","unstructured":"Horsman MR, Mortensen LS, Petersen JB, Busk M, Overgaard J. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol. 2012;9:674\u201387. https:\/\/doi.org\/10.1038\/nrclinonc.2012.171.","journal-title":"Nat Rev Clin Oncol"},{"key":"7625_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1158\/0008-5472.CAN-23-0523","volume":"83","author":"NR Fuentes","year":"2023","unstructured":"Fuentes NR, Taniguchi CM. Turning down oxygen to turn up inflammation in CAFs. Cancer Res. 2023;83:1560\u20132. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0523.","journal-title":"Cancer Res"},{"key":"7625_CR9","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1158\/0008-5472.CAN-22-2316","volume":"83","author":"S Schworer","year":"2023","unstructured":"Schworer S, Cimino FV, Ros M, Tsanov KM, Ng C, Lowe SW, et al. Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines. Cancer Res. 2023;83:1596\u2013610. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-2316.","journal-title":"Cancer Res"},{"key":"7625_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103209","volume":"74","author":"X Gu","year":"2024","unstructured":"Gu X, Zhu Y, Su J, Wang S, Su X, Ding X, et al. Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression. Redox Biol. 2024;74:103209. https:\/\/doi.org\/10.1016\/j.redox.2024.103209.","journal-title":"Redox Biol"},{"key":"7625_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314. https:\/\/doi.org\/10.1126\/science.123.3191.309.","journal-title":"Science"},{"issue":"18","key":"7625_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202500645","volume":"64","author":"Y Tian","year":"2025","unstructured":"Tian Y, Wang L, Chen R, Miao Y, Liu Y, Huang W, et al. Self-assembled triple-targeted radiosensitizer enhances hypoxic tumor targeting and radio-immunotherapy efficacy. Angew Chem Int Ed Engl. 2025;e202500645. https:\/\/doi.org\/10.1002\/anie.202500645.","journal-title":"Angew Chem Int Ed Engl"},{"key":"7625_CR13","doi-asserted-by":"publisher","first-page":"102300","DOI":"10.1016\/j.redox.2022.102300","volume":"52","author":"FB Rashed","year":"2022","unstructured":"Rashed FB, Diaz-Dussan D, Mashayekhi F, Macdonald D, Nation PN, Yang XH, et al. Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agents. Redox Biol. 2022;52:102300. https:\/\/doi.org\/10.1016\/j.redox.2022.102300.","journal-title":"Redox Biol"},{"key":"7625_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1021\/acs.jmedchem.4c02015","volume":"68","author":"Y Luo","year":"2025","unstructured":"Luo Y, Jin W, Zang J, Wang G, Zhu L, Kung HF. Development of [68Ga]Ga\/[177Lu]Lu-DOTA-NI-FAPI-04 containing a nitroimidazole moiety as new FAPI radiotracers with improved tumor uptake and retention. J Med Chem. 2025;68:348\u201360. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02015.","journal-title":"J Med Chem"},{"key":"7625_CR15","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","volume":"49","author":"R Lin","year":"2022","unstructured":"Lin R, Lin Z, Chen Z, Zheng S, Zhang J, Zang J, et al. [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2022;49:2960\u201371. https:\/\/doi.org\/10.1007\/s00259-022-05799-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7625_CR16","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.7150\/thno.79144","volume":"12","author":"J Zang","year":"2022","unstructured":"Zang J, Wen X, Lin R, Zeng X, Wang C, Shi M, et al. Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [68Ga]Ga-FAPI-RGD. Theranostics. 2022;12:7180\u201390. https:\/\/doi.org\/10.7150\/thno.79144.","journal-title":"Theranostics"},{"key":"7625_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL. Hypoxia\u2013a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38\u201347. https:\/\/doi.org\/10.1038\/nrc704.","journal-title":"Nat Rev Cancer"},{"key":"7625_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721\u201332. https:\/\/doi.org\/10.1038\/nrc1187.","journal-title":"Nat Rev Cancer"},{"key":"7625_CR19","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.2967\/jnumed.109.069021","volume":"50","author":"TG Lohith","year":"2009","unstructured":"Lohith TG, Kudo T, Demura Y, Umeda Y, Kiyono Y, Fujibayashi Y, et al. Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer. J Nucl Med. 2009;50:1948\u201353. https:\/\/doi.org\/10.2967\/jnumed.109.069021.","journal-title":"J Nucl Med"},{"key":"7625_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101905","volume":"41","author":"FB Rashed","year":"2021","unstructured":"Rashed FB, Stoica AC, MacDonald D, El-Saidi H, Ricardo C, Bhatt B, et al. Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins. Redox Biol. 2021;41:101905. https:\/\/doi.org\/10.1016\/j.redox.2021.101905.","journal-title":"Redox Biol"},{"key":"7625_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2020.06.004","volume":"489","author":"VM Todd","year":"2020","unstructured":"Todd VM, Johnson RW. Hypoxia in bone metastasis and osteolysis. Cancer Lett. 2020;489:144\u201354. https:\/\/doi.org\/10.1016\/j.canlet.2020.06.004.","journal-title":"Cancer Lett"},{"key":"7625_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neo.2022.01.003","volume":"25","author":"CP Carroll","year":"2022","unstructured":"Carroll CP, Bolland H, Vancauwenberghe E, Collier P, Ritchie AA, Clarke PA, et al. Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis. Neoplasia. 2022;25:41\u201352. https:\/\/doi.org\/10.1016\/j.neo.2022.01.003.","journal-title":"Neoplasia"},{"key":"7625_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.trecan.2016.05.006","volume":"2","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Nam JM, Giaccia AJ. Hypoxia: signaling the metastatic cascade. Trends Cancer. 2016;2:295\u2013304. https:\/\/doi.org\/10.1016\/j.trecan.2016.05.006.","journal-title":"Trends Cancer"},{"key":"7625_CR24","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s10120-017-0705-x","volume":"20","author":"K Okubo","year":"2017","unstructured":"Okubo K, Uenosono Y, Arigami T, Yanagita S, Matsushita D, Kijima T, et al. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer. Gastric Cancer. 2017;20:802\u201310. https:\/\/doi.org\/10.1007\/s10120-017-0705-x.","journal-title":"Gastric Cancer"},{"key":"7625_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21147\/j.issn.1000-9604.2019.01.12","volume":"31","author":"J Wang","year":"2019","unstructured":"Wang J, Wu P, Wang Z, Li K, Huang B, Wang P, et al. Metastatic patterns and surgical methods for lymph nodes 5 and 6 in proximal gastric cancer. Chin J Cancer Res. 2019;31:171\u20137. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.01.12.","journal-title":"Chin J Cancer Res"},{"key":"7625_CR26","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","volume":"60","author":"A Loktev","year":"2019","unstructured":"Loktev A, Lindner T, Burger EM, Altmann A, Giesel F, Kratochwil C, et al. Development of fibroblast activation protein-targeted radiotracers with improved tumor retention. J Nucl Med. 2019;60:1421\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.224469.","journal-title":"J Nucl Med"},{"key":"7625_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2967\/jnumed.119.233122","volume":"61","author":"T Watabe","year":"2020","unstructured":"Watabe T, Liu Y, Kaneda-Nakashima K, Shirakami Y, Lindner T, Ooe K, et al. Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu- and 225Ac-labeled FAPI-04 in pancreatic cancer xenograft mouse models. J Nucl Med. 2020;61:563\u20139. https:\/\/doi.org\/10.2967\/jnumed.119.233122.","journal-title":"J Nucl Med"},{"key":"7625_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s00259-020-04990-w","volume":"48","author":"S Ballal","year":"2021","unstructured":"Ballal S, Yadav MP, Kramer V, Moon ES, Roesch F, Tripathi M, et al. A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET\/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy. Eur J Nucl Med Mol Imaging. 2021;48:942\u20134. https:\/\/doi.org\/10.1007\/s00259-020-04990-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7625_CR29","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1158\/1078-0432.CCR-23-1983","volume":"29","author":"H Fu","year":"2023","unstructured":"Fu H, Huang J, Zhao T, Wang H, Chen Y, Xu W, et al. Fibroblast activation protein-targeted radioligand therapy with 177Lu-EB-FAPI for metastatic radioiodine-refractory thyroid cancer: first-in-human, dose-escalation study. Clin Cancer Res. 2023;29:4740\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1983.","journal-title":"Clin Cancer Res"},{"key":"7625_CR30","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-24-3918","volume":"31","author":"H Fu","year":"2025","unstructured":"Fu H, Huang J, Zhao L, Chen Y, Xu W, Cai J, et al. 177Lu-LNC1004 radioligand therapy in patients with end-stage metastatic cancers: a single-center, single-arm, phase II study. Clin Cancer Res. 2025. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-3918","journal-title":"Clin Cancer Res"},{"key":"7625_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","volume":"630","author":"XY Cui","year":"2024","unstructured":"Cui XY, Li Z, Kong Z, Liu Y, Meng H, Wen Z, et al. Covalent targeted radioligands potentiate radionuclide therapy. Nature. 2024;630:206\u201313. https:\/\/doi.org\/10.1038\/s41586-024-07461-6.","journal-title":"Nature"},{"key":"7625_CR32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, et al. 68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med. 2019;60:386\u201392. https:\/\/doi.org\/10.2967\/jnumed.118.215913.","journal-title":"J Nucl Med"},{"key":"7625_CR33","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","volume":"61","author":"C Meyer","year":"2020","unstructured":"Meyer C, Dahlbom M, Lindner T, Vauclin S, Mona C, Slavik R, et al. Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients. J Nucl Med. 2020;61:1171\u20137. https:\/\/doi.org\/10.2967\/jnumed.119.236786.","journal-title":"J Nucl Med"},{"key":"7625_CR34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2967\/jnumed.123.267281","volume":"65","author":"B Kline","year":"2024","unstructured":"Kline B, Yadav S, Seo Y, Ippisch RC, Castillo J, Aggarwal RR, et al. 68Ga-FAP-2286 PET of solid tumors: Biodistribution, Dosimetry, and comparison with 18F-FDG. J Nucl Med. 2024;65:938\u201343. https:\/\/doi.org\/10.2967\/jnumed.123.267281.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07625-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07625-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07625-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:39:02Z","timestamp":1771479542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07625-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7625"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07625-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article was modified to correct the funding statement.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institute Review Board of the First Affiliated Hospital, Fujian Medical University, and this study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Lin Zhu, Hank F. Kung hold the patent rights for DOTA-NI-FAPI-04 and related technology. The authors declare no financial or non-financial conflicts of interest related to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}